Finnish orthopedic device manufacturer Bone Index said it has won Medicare and Medicaid coverage for its Bindex point-of-care osteoporosis measurement device for ambulatory surgical and outpatient settings.
Bindex measures the cortical bone thickness of the tibia and an algorithm calculates the density index, a parameter that estimates bone mineral density at the hip as measured with a bone-density (DXA) scan. The device detects osteoporosis with 90% sensitivity and specificity and will significantly help physicians with diagnosis, according to the Helsinki-based company. The FDA approved Bindex in January 2017.
Get the full story on our sister site, Medical Design & Outsourcing.
The post Bone Index wins CMS coverage for osteoporosis diagnostic device appeared first on MassDevice.
from MassDevice https://ift.tt/2KTpDOx
Cap comentari:
Publica un comentari a l'entrada